AUG 15, 2021 5:52 PM PDT

A COVID-19 Vaccine Booster Now Recommended for Immunocompromised People

WRITTEN BY: Carmen Leitch

As Delta has become the dominant SARS-CoV-2 variant causing COVID-19 infections in the United States, researchers and health officials have been trying to determine whether the current vaccines can protect against this particularly contagious variant. Right now, the answer seems to be yes, the mRNA vaccines produced by Pfizer and Moderna are effective against the Delta variant, especially at preventing hospitalizations and deaths.

However, recent pre-printed work (not yet peer-reviewed) has suggested that the efficacy of these vaccines may decline as more unvaccinated people become infected and contagious. However, the work needs to be evaluated further before we can draw solid conclusions from it. Learn more about breakthrough infections from the video.

Related: COVID-19 Delta Variant Seems to Grow Faster & Be More Contagious

Officials are understandably eager to get as may people vaccinated as possible, for many reasons. For example, it's important to reduce the strain on our healthcare system, and the faster we can reduce the spread of the SARS-CoV-2 virus, the fewer chances it will have to mutate into other variants as well.

The Centers for Disease Control and Prevention (CDC), the Food and Drug Administration and other organizations are beginning to assess whether COVID-19 vaccine booster shots will be needed.

Colorized scanning electron micrograph of a cell (teal and green) infected with SARS-CoV-2 virus particles (purple and pink), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID

As of August 13, 2021, vaccine boosters have been authorized for a small number of people in select groups. According to CDC recommendations, the following individuals are eligible to receive an additional dose of the 2-dose vaccine they received. It's too soon to know whether an additional dose of the Johnson & Johnson (J&J) vaccine will provide any additional protection, so another J&J dose is not recommended at this time. Patients on the following list (copied directly from the CDC) who got a Pfizer vaccine should get another Pfizer dose if desired, and those who received a Moderna vaccine would get another Moderna dose if desired.

  •     "Active treatment for solid tumor and hematologic malignancies
  •     Receipt of solid-organ transplant and taking immunosuppressive therapy
  •     Receipt of CAR-T-cell or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
  •     Moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome)
  •     Advanced or untreated HIV infection
  •     Active treatment with high-dose corticosteroids (i.e., ≥20mg prednisone or equivalent per day), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor-necrosis (TNF) blockers, and other biologic agents that are immunosuppressive or immunomodulatory."

Right now, COVID-19 is surging in the United States again. About 129,000 new cases are being reported daily. It's estimated that 51 percent of Americans are fully vaccinated and about 60 percent have gotten one dose. Right now, approval to give the COVID-19 vaccines to children under age 12 is expected around mid-winter, though the United States is asking for approval to be fast-tracked. Results from trials are expected in the fall, and those results will have to be reviewed.

Researchers will be continuing to assess whether boosters will be needed for the elderly, or the general population. Unfortunately, the general public is unaccustomed to rapidly-changing and updated information regarding infectious disease, and keeping up with these shifts in knowledge has been challenging and confusing for many.

Source: CDC

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 06, 2022
Cancer
Breakthrough COVID Cases Cause Concern for Cancer Patients
JAN 06, 2022
Breakthrough COVID Cases Cause Concern for Cancer Patients
As we enter the third year of the COVID-19 pandemic, we continue to learn more about the respiratory virus leading to a ...
FEB 01, 2022
Coronavirus
A Genetic Variant Can Protect Against Severe COVID-19
FEB 01, 2022
A Genetic Variant Can Protect Against Severe COVID-19
The wide variation in the severity of COVID cases is probably due to a wide range of factors, including how much virus a ...
MAR 29, 2022
Drug Discovery & Development
Nasal Spray Shows Promise Against All Variants of SARS-CoV-2
MAR 29, 2022
Nasal Spray Shows Promise Against All Variants of SARS-CoV-2
A compound delivered via a nasal spray can prevent and treat various COVID-19 variants in mice. The corresponding study ...
APR 01, 2022
Cannabis Sciences
Can weed cure Covid?
APR 01, 2022
Can weed cure Covid?
Since legal cannabis has gained momentum throughout the country, so have the reports that it's the cure all for everythi ...
APR 14, 2022
Drug Discovery & Development
COVID-19 Drug Combo More Effective than Single Drugs
APR 14, 2022
COVID-19 Drug Combo More Effective than Single Drugs
COVID-19 is more effectively treated by a combination of drugs than singular drugs alone. The corresponding study was pu ...
JUL 10, 2022
Health & Medicine
How COVID Vaccine Mandates Worked Out for Countries
JUL 10, 2022
How COVID Vaccine Mandates Worked Out for Countries
Now that we’ve made it to the summer of 2022, about 2 and a half years after the pandemic started in the U.S., it& ...
Loading Comments...